查看购物车
  • Traditional Chinese
  • English
南美洲和中美洲体外诊断市场预测至 2030 年 - 区域分析 - 按产品和服务、技术、应用和最终用户
市场调查报告书
商品编码
1463557

南美洲和中美洲体外诊断市场预测至 2030 年 - 区域分析 - 按产品和服务、技术、应用和最终用户

South & Central America In-Vitro Diagnostics Market Forecast to 2030 - Regional Analysis - by Product & Services, Technology, Application, and End User
出版日期: | 出版商: The Insight Partners | 英文 113 Pages | 订单完成后即时交付

价格

南美洲和中美洲体外诊断市场预计将从2022年的58.7417亿美元CAGR到2030年的84.7811亿美元。

IVD 技术与数位健康解决方案的整合推动南美洲和中美洲体外诊断市场

IVD 用于临床、实验室和门诊环境，其具体目的是帮助检测疾病，从而帮助选择适当的治疗方案。 IVD 技术与数位健康解决方案的整合正在全球范围内受到关注。数据分析、人工智慧和远端监控增强了诊断测试的价值，从而实现更好的患者管理和结果。与数位健康解决方案整合的 IVD 技术可以纳入临床决策支援系统。正如世界卫生组织所认识到的，数位健康解决方案可以帮助检测疾病。人工智慧健康机器人和其他类似的新兴解决方案可能会为患者护理带来机会，并解决高成本和时间要求等挑战。在基于基因组测试的诊断中，深度学习可以识别癌细胞，确定其类型，并根据特定样本的图像预测肿瘤中可能发生哪些突变。体外诊断中的人工智慧和机器学习 (AI/ML) 正在彻底改变医疗设备的开发。这些现代诊断系统促进基于数位影像分析的诊断，从而改善医疗决策。智慧诊断是一种可扩展性极强的 IVD 解决方案，它使用人工智慧，其性能优于基于实验室的诊断，而价格仅为实验室诊断的一小部分。此外，这种类型的诊断可以透过独特的化学和生物特征检测和分析来得出新兴特征。因此，IVD 与数位健康技术的整合可能会在未来几年为体外诊断市场提供利润丰厚的机会。

南美洲和中美洲体外诊断市场概述

南美洲和中美洲体外诊断市场已细分为巴西、阿根廷以及南美洲和中美洲其他地区。由于慢性病患病率较高、诊断设施数量不断增加以及医疗保健基础设施不断发展，预计该地区的体外诊断市场将在预测期内增长。上述因素对南美洲和中美洲地区体外诊断市场的成长有重要影响。巴西是南美洲和中美洲最大的市场。支持性政府、利润丰厚的医疗保健政策、发展中的经济和先进的医疗保健基础设施等因素为采用现代诊断技术创造了空间。此外，慢性病和传染病的日益普及预计将推动该国体外诊断市场的成长。根据国际糖尿病联合会发布的一项研究，该国的糖尿病人口预计将从 2021 年的 1570 万增至 2045 年的 2180 万。体外诊断市场的许多主要参与者采取策略性倡议，透过巴西的地理扩张来巩固其市场。例如，2022 年 8 月，费森尤斯·卡比 (Fresenius Kabi) 与 Bio-Manguinhos/Fiocruz 和 Bionovis 合作，在巴西提供阿达木单抗生物相似药。此次合作将扩大巴西公共卫生系统 (SUS) 中多种自体免疫疾病的治疗选择。

此外，巴西的老年人口正在高速成长。例如，根据泛美卫生组织统计，巴西60岁及以上人口超过3,000万，占该国人口的13%。在开发和随后实施个人化医疗中使用分子诊断技术可能会促进巴西市场的成长。 2020年2月28日，Cepheid和Sherlock Biosciences合作探索开发新的尖端分子诊断测试。此次合作将重点开发肿瘤疾病和传染病的分子诊断测试。巴西是拉丁美洲最大的医疗保健市场，其 GDP 的 9.1% 用于医疗保健。 2021年，巴西医疗器材进口额成长7.3%，达62亿美元。巴西政府是医疗保健产品的主要买家，这些产品供应给公共医疗保健系统。根据国际贸易管理局的数据，2021 年巴西进口了价值 3.17 亿美元的 CBDL 体外诊断试剂和设备。

南美洲和中美洲体外诊断市场收入及 2030 年预测（百万美元）

南美洲和中美洲体外诊断市场细分

南美洲和中美洲体外诊断市场分为产品和服务、技术、应用、最终用户和国家。

根据产品和服务，南美洲和中美洲体外诊断市场分为试剂和试剂盒、仪器以及软体和服务。 2022 年，试剂和试剂盒细分市场在南美洲和中美洲体外诊断市场中占据最大份额。

根据技术，南美洲和中美洲体外诊断市场分为免疫测定/免疫化学、临床化学、分子诊断、微生物学、血糖自我监测、凝血和止血、血液学、尿液分析等。 2022 年，免疫分析/免疫化学领域在南美洲和中美洲体外诊断市场中占据最大份额。

根据应用，南美洲和中美洲体外诊断市场分为传染病、糖尿病、肿瘤学、心臟病学、自体免疫疾病、肾臟病学等。 2022 年，传染病领域在南美洲和中美洲体外诊断市场中占据最大份额。

根据最终用户，南美洲和中美洲体外诊断市场分为医院、实验室、家庭护理等。 2022 年，医院细分市场在南美洲和中美洲体外诊断市场中占据最大份额。

根据国家/地区，南美洲和中美洲体外诊断市场分为巴西、阿根廷以及南美洲和中美洲其他地区。 2022 年，巴西在南美洲和中美洲体外诊断市场占据主导地位。

Abbott Laboratories、Becton Dickinson and Co、bioMerieux SA、Bio-Rad Laboratories Inc、Danaher Corp、F. Hoffmann-La Roche Ltd、Qiagen NV、Siemens AG、Sysmex Corp 和Thermo Fisher Scientific Inc 是在这些地区运营的一些领先公司。

目录

第 1 章：简介

第 2 章：执行摘要

  • 重要见解

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：南美洲和中美洲体外诊断市场 - 主要产业动态

  • 主要市场驱动因素
    • 慢性病和传染病的盛行率不断增加
    • COVID-19 大流行期间床边检测的成长和 IVD 需求的激增
  • 市场约束
    • 监理框架和报销政策不足
  • 市场机会
    • IVD 与数位健康科技的整合
  • 未来的趋势
    • 对个人化医疗和基因组学的需求不断增长

第 5 章：体外诊断市场 - 南美洲和中美洲市场分析

  • 南美洲和中美洲体外诊断市场收入，2022 - 2030

第 6 章：南美洲和中美洲体外诊断市场 - 收入和 2030 年预测 - 按产品和服务

  • 概述
  • 2022 年和 2030 年南美洲和中美洲体外诊断市场收入份额（按产品和服务划分）
  • 试剂和试剂盒
  • 软体和服务
  • 仪器

第 7 章：南美洲和中美洲体外诊断市场 - 收入和 2030 年预测 - 按技术

  • 概述
  • 2022 年和 2030 年南美洲和中美洲体外诊断市场收入份额（按技术划分）
  • 免疫测定/免疫化学
  • 临床化学
  • 分子诊断
  • 微生物学
  • 血糖自我监测
  • 凝血与止血
  • 血液学
  • 尿液分析
  • 其他的

第 8 章：南美洲和中美洲体外诊断市场 - 收入和 2030 年预测 - 按应用

  • 概述
  • 2022 年和 2030 年南美洲和中美洲体外诊断市场收入份额（按应用划分）
  • 传染病
  • 糖尿病
  • 肿瘤学
  • 心臟病学
  • 自体免疫疾病
  • 肾臟病学
  • 其他的

第 9 章：南美洲和中美洲体外诊断市场 - 收入和 2030 年预测 - 按最终用户

  • 概述
  • 2022 年和 2030 年南美洲和中美洲体外诊断市场收入份额（按最终用户划分）（%）
  • 医院
  • 实验室
  • 居家护理
  • 其他的

第 10 章：南美洲和中美洲体外诊断市场 - 收入和 2030 年预测 - 国家分析

  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区

第 11 章：产业格局

  • 有机发展
    • 概述
  • 无机发展
    • 概述

第 12 章：公司简介

  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd
  • Danaher Corp
  • Siemens AG
  • Sysmex Corp
  • Thermo Fisher Scientific Inc
  • Becton Dickinson and Co
  • bioMerieux SA
  • Bio-Rad Laboratories Inc
  • Qiagen NV

第 13 章：附录

Product Code: TIPRE00022126

The South & Central America in-vitro diagnostics market is expected to grow from US$ 5,874.17 million in 2022 to US$ 8,478.11 million by 2030. It is estimated to grow at a CAGR of 4.7% from 2022 to 2030.

Integration of IVD Technologies with Digital Health Solutions Fuels South & Central America In-Vitro Diagnostics Market

IVD is used in clinical, laboratory, and outpatient settings with the aim specifically to help in the detection of diseases and, consequently, aid in the selection of appropriate treatment protocols. The integration of IVD technologies with digital health solutions is gaining traction globally. Data analytics, artificial Intelligence, and remote monitoring enhance the value of diagnostic tests, leading to better patient management and outcomes. IVD technologies integrated with digital health solutions can be incorporated into clinical decision support systems. As recognized by the WHO, digital health solutions could help detect diseases. Artificial intelligence health bots and similar other emerging solutions may present opportunities for patient care and address challenges such as high cost and time requirements. In diagnostics based on genomic testing, deep learning can identify cancer cells, determine their type, and predict what mutations may occur in a tumor from images of a specific sample. Artificial intelligence and machine learning (AI/ML) in in-vitro diagnostics are revolutionizing medical device development. These modern diagnostic systems facilitate diagnosis based on digital image analysis, thereby improving healthcare decision-making. Smart diagnostics are extremely scalable IVD solutions that use artificial intelligence to perform better than lab-based diagnostics at a fraction of the price. Additionally, this type of diagnostics can derive emergent features through unique chemical and biological signature detection and analysis. Thus, the integration of IVD with digital health technologies is likely to offer lucrative opportunities to the in-vitro diagnostics market in the coming years.

South & Central America In-Vitro Diagnostics Market Overview

The South & Central America in-vitro diagnostics market has been segmented into Brazil, Argentina, and the Rest of South & Central America. The market for in-vitro diagnostics in the region is expected to grow during the forecast period owing to the higher prevalence of chronic conditions, increasing number of diagnostic facilities, and developing healthcare infrastructure. The aforementioned factors are responsible for influential growth of in-vitro diagnostics market in the South & Central America region. Brazil is the largest market in South & Central America. Factors such as supportive government, lucrative healthcare policies, a developing economy, and advancing healthcare infrastructure create scope for adopting modern technologies in diagnostics. Additionally, the increasing prevalence of chronic conditions and infectious diseases is projected to drive the growth of the in-vitro diagnostics market in the country. According to a study published by the International Diabetes Federation, the diabetic population of the country is projected to reach 21.8 million by 2045 from 15.7 million in 2021. Also, according to the estimates, Brazil has the fifth largest diabetic population in the world. A number of major players in the in-vitro diagnostics market take strategic initiatives to consolidate their market through geographic expansions in Brazil. For instance, in August 2022, Fresenius Kabi partnered with Bio-Manguinhos/Fiocruz and Bionovis to provide access to adalimumab biosimilar in Brazil. This partnership will expand treatment options for several autoimmune diseases in the Brazilian Public Health System (SUS).

Additionally, Brazil is witnessing a high rate of growth in the geriatric population. For instance, according to the Pan American Health Organization, Brazil has more than 30 million people aged 60 years or more, which represents 13% of the country's population. The use of molecular diagnostic techniques in developing and, subsequently, administering personalized medicine is likely to boost the market growth in Brazil. On February 28, 2020, Cepheid and Sherlock Biosciences collaborated to explore the development of new cutting-edge molecular diagnostic tests. The collaboration will focus on the development of molecular diagnostic tests for oncological conditions and infectious diseases. Brazil is the largest healthcare market in Latin America, spending 9.1% of its GDP on healthcare. In 2021, Brazil added the imports of medical devices by 7.3%, reaching US$ 6.2 billion. The Government of Brazil is a key buyer of healthcare products, which supply them to the public healthcare system. As per the International Trade Administration ~US$ 317 million CBDL in vitro diagnostic reagents and equipment were imported into Brazil in 2021. Thus, the developing economy and growing diabetes prevalence fuels the in-vitro diagnostics market growth in Brazil.

South & Central America In-Vitro Diagnostics Market Revenue and Forecast to 2030 (US$ Million)

South & Central America In-Vitro Diagnostics Market Segmentation

The South & Central America in-vitro diagnostics market is segmented into product & services, technology, application, end user, and country.

Based on product & services, the South & Central America in-vitro diagnostics market is segmented into reagents & kits, instruments, and software & services. The reagents & kits segment held the largest share of the South & Central America in-vitro diagnostics market in 2022.

Based on technology, the South & Central America in-vitro diagnostics market is segmented into immunoassay/ immunochemistry, clinical chemistry, molecular diagnostics, microbiology, blood glucose self-monitoring, coagulation & hemostasis, hematology, urinalysis, and others. The immunoassay/ immunochemistry segment held the largest share of the South & Central America in-vitro diagnostics market in 2022.

Based on application, the South & Central America in-vitro diagnostics market is segmented into infectious diseases, diabetes, oncology, cardiology, autoimmune diseases, nephrology, and others. The infectious diseases segment held the largest share of the South & Central America in-vitro diagnostics market in 2022.

Based on end user, the South & Central America in-vitro diagnostics market is segmented into hospitals, laboratories, homecare, and others. The hospitals segment held the largest share of the South & Central America in-vitro diagnostics market in 2022.

Based on country, the South & Central America in-vitro diagnostics market is segmented int o Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America in-vitro diagnostics market in 2022.

Abbott Laboratories, Becton Dickinson and Co, bioMerieux SA, Bio-Rad Laboratories Inc, Danaher Corp, F. Hoffmann-La Roche Ltd, Qiagen NV, Siemens AG, Sysmex Corp, and Thermo Fisher Scientific Inc are some of the leading companies operating in the South & Central America in-vitro diagnostics market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. South & Central America In-Vitro Diagnostics Market - Key Industry Dynamics

  • 4.1 Key Market Drivers
    • 4.1.1 Increasing Prevalence of Chronic and Infectious Diseases
    • 4.1.2 Growth in Point-of-Care Testing and Surge in Demand for IVD during COVID-19 Pandemic
  • 4.2 Market Restraint
    • 4.2.1 Insufficiency of Regulatory Frameworks and Reimbursement Policies
  • 4.3 Market Opportunities
    • 4.3.1 Integration of IVD with Digital Health Technologies
  • 4.4 Future Trends
    • 4.4.1 Increasing Demand for Personalized Medicine and Genomics

5. In-Vitro Diagnostics Market - South & Central America Market Analysis

  • 5.1 South & Central America In-Vitro Diagnostics Market Revenue (US$ Mn), 2022 - 2030

6. South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - by Product and Services

  • 6.1 Overview
  • 6.2 South & Central America In-Vitro Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
  • 6.3 Reagents and Kits
    • 6.3.1 Overview
    • 6.3.2 Reagents and Kits: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Software and Services
    • 6.4.1 Overview
    • 6.4.2 Software and Services: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.5 Instruments
    • 6.5.1 Overview
    • 6.5.2 Instruments: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

7. South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - by Technology

  • 7.1 Overview
  • 7.2 South & Central America In-Vitro Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
  • 7.3 Immunoassay/ Immunochemistry
    • 7.3.1 Overview
    • 7.3.2 Immunoassay/ Immunochemistry: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Clinical Chemistry
    • 7.4.1 Overview
    • 7.4.2 Clinical Chemistry: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Molecular Diagnostics
    • 7.5.1 Overview
    • 7.5.2 Molecular Diagnostics: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Microbiology
    • 7.6.1 Overview
    • 7.6.2 Microbiology: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Blood Glucose Self-Monitoring
    • 7.7.1 Overview
    • 7.7.2 Blood Glucose Self-Monitoring: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.8 Coagulation and Hemostasis
    • 7.8.1 Overview
    • 7.8.2 Coagulation and Hemostasis: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.9 Hematology
    • 7.9.1 Overview
    • 7.9.2 Hematology: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.10 Urinalysis
    • 7.10.1 Overview
    • 7.10.2 Urinalysis: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.11 Others
    • 7.11.1 Overview
    • 7.11.2 Others: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

8. South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - by Application

  • 8.1 Overview
  • 8.2 South & Central America In-Vitro Diagnostics Market Revenue Share, by Application 2022 & 2030 (%)
  • 8.3 Infectious Disease
    • 8.3.1 Overview
    • 8.3.2 Infectious Diseases: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Diabetes
    • 8.4.1 Overview
    • 8.4.2 Diabetes: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Oncology
    • 8.5.1 Overview
    • 8.5.2 Oncology: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Cardiology
    • 8.6.1 Overview
    • 8.6.2 Cardiology: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Autoimmune Diseases
    • 8.7.1 Overview
    • 8.7.2 Autoimmune Diseases: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.8 Nephrology
    • 8.8.1 Overview
    • 8.8.2 Nephrology: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.9 Others
    • 8.9.1 Overview
    • 8.9.2 Others: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

9. South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - by End User

  • 9.1 Overview
  • 9.2 South & Central America In-Vitro Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
  • 9.3 Hospitals
    • 9.3.1 Overview
    • 9.3.2 Hospitals: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Laboratories
    • 9.4.1 Overview
    • 9.4.2 Laboratories: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Homecare
    • 9.5.1 Overview
    • 9.5.2 Homecare: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

10. South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - Country Analysis

  • 10.1 South & Central America In-Vitro Diagnostics Market
    • 10.1.1 Overview
    • 10.1.2 South & Central America In-Vitro Diagnostics Market, by Country
      • 10.1.2.1 Brazil: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.1.1 Overview
        • 10.1.2.1.2 Brazil: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.1.3 Brazil: South & Central America In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
        • 10.1.2.1.4 Brazil: South & Central America In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.2.1.5 Brazil: South & Central America In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
        • 10.1.2.1.6 Brazil: South & Central America In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
      • 10.1.2.2 Argentina: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.2.1 Overview
        • 10.1.2.2.2 Argentina: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.2.3 Argentina: South & Central America In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
        • 10.1.2.2.4 Argentina: South & Central America In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.2.2.5 Argentina: South & Central America In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
        • 10.1.2.2.6 Argentina: South & Central America In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
      • 10.1.2.3 Rest of South & Central America: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.3.1 Overview
        • 10.1.2.3.2 Rest of South & Central America: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.3.3 Rest of South & Central America: South & Central America In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
        • 10.1.2.3.4 Rest of South & Central America: South & Central America In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.2.3.5 Rest of South & Central America: South & Central America In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
        • 10.1.2.3.6 Rest of South & Central America: South & Central America In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)

11. Industry Landscape

  • 11.1 Organic Developments
    • 11.1.1 Overview
  • 11.2 Inorganic Developments
    • 11.2.1 Overview

12. Company Profiles

  • 12.1 Abbott Laboratories
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 F. Hoffmann-La Roche Ltd
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Danaher Corp
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Siemens AG
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Sysmex Corp
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Thermo Fisher Scientific Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Becton Dickinson and Co
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 bioMerieux SA
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Bio-Rad Laboratories Inc
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Qiagen NV
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. South & Central America In-Vitro Diagnostics Market Segmentation
  • Table 2. Brazil South & Central America In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. Brazil South & Central America In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. Brazil South & Central America In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. Brazil South & Central America In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. Argentina South & Central America In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. Argentina South & Central America In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. Argentina South & Central America In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. Argentina South & Central America In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. Rest of South & Central America South & Central America In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Rest of South & Central America South & Central America In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. Rest of South & Central America South & Central America In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. Rest of South & Central America South & Central America In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. Organic Developments Done by Companies
  • Table 15. Inorganic Developments Done by Companies
  • Table 16. Glossary of Terms, South & Central America In-Vitro Diagnostics Market

List Of Figures

  • Figure 1. South & Central America In-Vitro Diagnostics Market Segmentation, By Country
  • Figure 2. South & Central America In-Vitro Diagnostics Market: Key Industry Dynamics
  • Figure 3. South & Central America In-Vitro Diagnostics Market: Impact Analysis of Drivers and Restraints
  • Figure 4. South & Central America In-Vitro Diagnostics Market Revenue (US$ Mn), 2020 - 2030
  • Figure 5. South & Central America In-Vitro Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
  • Figure 6. Reagents and Kits: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Software and Services: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Instruments: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. South & Central America In-Vitro Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
  • Figure 10. Immunoassay/ Immunochemistry: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Clinical Chemistry: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Molecular Diagnostics: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Microbiology: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Blood Glucose Self-Monitoring: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Coagulation and Hemostasis: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Hematology: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Urinalysis: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Others: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. South & Central America In-Vitro Diagnostics Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 20. Infectious Diseases: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Diabetes: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Oncology: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Cardiology: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Autoimmune Diseases: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Nephrology: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. Others: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. South & Central America In-Vitro Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
  • Figure 28. Hospitals: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. Laboratories: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 30. Homecare: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 31. Others: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 32. South & Central America: South & Central America In-Vitro Diagnostics Market, By Key Country - Revenue (2022) (US$ Million)
  • Figure 33. South & Central America In-Vitro Diagnostics Market, by Country, 2022 & 2030 (%)
  • Figure 34. Brazil: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 35. Argentina: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 36. Rest of South & Central America: South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)